Variant report
Variant | rs12623172 |
---|---|
Chromosome Location | chr2:99485926-99485927 |
allele | C/T |
Outlinks | Ensembl   UCSC |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:99481400-99486400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
2 | chr2:99481400-99486400 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr2:99481800-99487000 | Weak transcription | Lung | lung |
4 | chr2:99483000-99486000 | Weak transcription | HSMM | muscle |
5 | chr2:99484000-99489000 | Weak transcription | Stomach Smooth Muscle | stomach |
6 | chr2:99484200-99486600 | Flanking Active TSS | Hela-S3 | cervix |
7 | chr2:99484600-99486200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
8 | chr2:99484600-99486400 | Flanking Active TSS | NHEK | skin |
9 | chr2:99484800-99486200 | Active TSS | Esophagus | oesophagus |
10 | chr2:99484800-99486200 | Weak transcription | Skeletal Muscle Female | skeletal muscle |
11 | chr2:99484800-99486400 | Flanking Active TSS | Fetal Intestine Large | intestine |
12 | chr2:99485000-99486000 | Active TSS | Rectal Mucosa Donor 29 | rectum |
13 | chr2:99485000-99486200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
14 | chr2:99485000-99486200 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin02 | Skin |
15 | chr2:99485000-99486400 | Flanking Active TSS | Foreskin Keratinocyte Primary Cells skin03 | Skin |
16 | chr2:99485000-99486400 | Active TSS | Rectal Smooth Muscle | rectum |
17 | chr2:99485000-99486800 | Active TSS | Duodenum Mucosa | Duodenum |
18 | chr2:99485000-99488200 | Enhancers | Fetal Muscle Leg | muscle |
19 | chr2:99485200-99486000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
20 | chr2:99485200-99486200 | Flanking Active TSS | HMEC | breast |
21 | chr2:99485200-99487400 | Weak transcription | Brain Angular Gyrus | brain |
22 | chr2:99485200-99487800 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
23 | chr2:99485400-99486000 | Weak transcription | Brain Inferior Temporal Lobe | brain |
24 | chr2:99485400-99486200 | Flanking Bivalent TSS/Enh | HepG2 | liver |
25 | chr2:99485400-99486400 | Enhancers | H1 Cell Line | embryonic stem cell |
26 | chr2:99485400-99486400 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
27 | chr2:99485400-99486400 | Flanking Active TSS | Fetal Intestine Small | intestine |
28 | chr2:99485400-99486400 | Active TSS | Gastric | stomach |
29 | chr2:99485400-99486600 | Active TSS | Colonic Mucosa | Colon |
30 | chr2:99485400-99486600 | Flanking Active TSS | Pancreas | Pancrea |
31 | chr2:99485400-99486800 | Enhancers | Placenta | Placenta |
32 | chr2:99485400-99487400 | Enhancers | Fetal Muscle Trunk | muscle |
33 | chr2:99485600-99486000 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin01 | Skin |
34 | chr2:99485600-99486000 | Active TSS | Rectal Mucosa Donor 31 | rectum |
35 | chr2:99485600-99486400 | Active TSS | Stomach Mucosa | stomach |
36 | chr2:99485600-99499800 | Weak transcription | Brain Dorsolateral Prefrontal Cortex | brain |
37 | chr2:99485800-99486200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
38 | chr2:99485800-99486600 | Enhancers | Placenta Amnion | Placenta Amnion |
39 | chr2:99485800-99486800 | Enhancers | GM12878-XiMat | blood |
40 | chr2:99485800-99487000 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
41 | chr2:99485800-99488200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
42 | chr2:99485800-99491800 | Weak transcription | Brain Anterior Caudate | brain |